Neospora caninum: a new class of biopharmaceuticals in the therapeutic arsenal against cancer. - Lantier L; Poupée-Beaugé A; di Tommaso A; Ducournau C; Epardaud M; Lakhrif Z; Germon S; Debierre-Grockiego F; Mévélec MN; Battistoni A; Coënon L; Deluce-Kakwata-Nkor N; et al. (Journal for immunotherapy of cancer, 2020)